Candel Therapeutics (CADL)

• Market cap: $315M
• 1 day: -5.9%
• 5 days: -8.6%
• 1 month: -1.03%
• 3 months: 2.5%
• 6 months: -16.33%
• Year to date: 5.51%
• 1 year: -14.33%
• 5 years: -18%
• 10 years: -18%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38